Clinical Trial Patient Technology Articles

  1. A Quick & Easy Guide To Site-Facing Clinical Trial Technologies 8/15/2024

    Consultant Aurea Flores, Ph.D. summarizes some of the clinical trial technologies used by clinical research sites, their capabilities, and how sponsors and sites might best evaluate their use in clinical research.

  2. Some Truths You Can't Avoid About eCOA 8/13/2024

    The advantages of eCOA systems often overshadow some of the potential challenges they could create. Robert Goldman expounds on some of his first-hand experiences over the years with ePRO and eCOA implementations that went awry.

  3. What Drives eConsent Adoption? Reasons May Be Different Than You Think 6/13/2024

    Increasing efficiency and reducing cost are significant drivers for adopting eConsent platforms. But are they really the factors holding back widespread adoption? Gatewood Global Principal Jeanie Magdalena Gatewood reveals other drivers in her independent research.

  4. eCOA Solutions: Trends, Benefits, & Buying In 2024 2/22/2024

    The eCOA solution market is anticipated to capture $15.1 billion by the year 2036, growing at a CAGR of almost 15.1% during the forecast period. Learn more with this market outlook.

  5. Embracing Hybrid Trial Design — How, When, & Why To Use It 6/28/2023

    Global Clinical Sciences & Operations Innovation Lead Lewis Millen talks about UCB’s approach to hybrid trial design, how and when it chooses to implement remote and virtual elements, and why a hybrid trial is beneficial to both the sponsor and the patient.

  6. How PROs Enhance Patient Care Decisions And Future Clinical Research 6/12/2023

    Patient-reported outcomes (PROs) offer unique insights that complement traditional treatment efficacy endpoints, such as survival or disease relapse, and can facilitate better discussions between clinicians and patients. When PROs are incorporated into clinical trial protocols, sponsors can gain a better understanding of the treatment’s impact from the patient’s perspective. 

  7. The 5Vs Of Collecting Clinical Data 1/26/2023

    Not all data is created equal. Our data strategies need to be commensurate with the risks, complexity, and value of the data collected. If the true value of data is to be realized, it must be collected and captured in accordance with the five “V” dimensions: volume, variety, velocity, veracity, and value.

  8. Two Straightforward Ways To Improve DE&I In Clinical Trials 12/27/2022

    We don’t have to wait for federal guidance, additional DHT, or new innovations. We have the tools to begin to address the lack of trust and limited data and incorporate them into diversity plans for clinical trials today. Here's how.

  9. Boehringer Ingelheim Implements One Medicine Technology Platform 12/8/2022

    For years, Boehringer Ingelheim operated with a system comprised of best-of-breed solutions from different vendor companies. After carefully evaluating the technology environment, the company decided to move from best-of-breed solutions to an end-to-end product development platform.

  10. What Your Sites Love And Hate About DCTs 10/25/2022

    For years, sponsor companies have had access to new and emerging technologies that would ease the participation burden of patients in clinical trials. While these emerging technologies helped sponsor companies keep their trials on track, they have also been a burden for the clinical sites having to deal with the changes required to keep up with them. Do you know where your sites stand on the adoption of hybrid trials and DCTs?